BiotechTube
Discover
News
Company
Sign in
BiotechTube
Home
/
KaliVir Immunotherapeutics
/
James M. Burke, M.D.
JM
James M. Burke, M.D.
Chief Medical Officer
KaliVir Immunotherapeutics
Therapeutic Areas
Oncology
KaliVir Immunotherapeutics Pipeline
Drug
Indication
Phase
VET3-TGI
Advanced Solid Tumors
Phase 1
Leadership Team at KaliVir Immunotherapeutics
UF
Ursula Fritsch, PharmD
Chief Regulatory Officer
SG
Schond Greenway
Chief Financial Officer
AP
Adina Pelusio
Chief Development Officer
PY
Paul Youm
Vice President, Corporate Development and Alliance Management
View full KaliVir Immunotherapeutics profile